Iovance Biotherapeutics, Inc. (IOVA) total assets

Total assets · fiscal 2025
$913.17M

Iovance Biotherapeutics, Inc. (IOVA) had total assets of $913.17M at the end of fiscal 2025 (December 31, 2025). That is 0.3% higher than the $910.43M of fiscal 2024. Figures as of 18 Nov 2026, 10:45 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$913.17M
Change on fiscal 2024
+0.3%
Growth, 5 years
+3.5% a year
Growth, 10 years
+24.1% a year
Highest on record
$913.17Mfiscal 2025
Lowest on record
$29.41Kfiscal 2012
Fiscal years on record
162010–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Iovance Biotherapeutics, Inc. total assets, in more detail

Over the five fiscal years to 2025 total assets grew at a compound 3.5% a year; over ten years the rate was 24.1% a year. Across the 16 fiscal years on record (2010–2025), the highest was $913.17M in fiscal 2025 and the lowest $29.41K in fiscal 2012.

History · 16 fiscal years

Total assets by fiscal year

Iovance Biotherapeutics, Inc. total assets, year by year

Iovance Biotherapeutics, Inc. (IOVA) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$913.17M 0.3% up
2024$910.43M 16.7% up
2023$780.35M 17.5% up
2022$663.98M 14.6% down
2021$777.33M 1.2% up
2020$768.46M 123.0% up
2019$344.66M 28.3% down
2018$480.82M 209.5% up
2017$155.37M 9.6% down
2016$171.89M 62.7% up
2015$105.65M 127.2% up
2014$46.51M 134.0% up
2013$19.87M 67,467.6% up
2012$29.41K 94.8% down
2011$568.43K 61.1% down
2010$1.46M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

More on IOVA

Iovance Biotherapeutics, Inc., figure by figure

Iovance Biotherapeutics, Inc. (IOVA) overview: price, valuation and scorecard

Iovance Biotherapeutics, Inc. total assets: questions and answers

How large are Iovance Biotherapeutics, Inc.'s total assets?

Iovance Biotherapeutics, Inc. (IOVA) had total assets of $913.17M at the end of fiscal 2025 (December 31, 2025). That is 0.3% higher than the $910.43M of fiscal 2024.

What is the growth rate of Iovance Biotherapeutics, Inc.'s total assets?

Over the five fiscal years to 2025 total assets grew at a compound 3.5% a year; over ten years the rate was 24.1% a year.

What are the highest and lowest total assets figures on record for Iovance Biotherapeutics, Inc.?

Across the 16 fiscal years on record (2010–2025), the highest was $913.17M in fiscal 2025 and the lowest $29.41K in fiscal 2012.

How is Iovance Biotherapeutics, Inc.'s total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest. For Iovance Biotherapeutics, Inc. it is on record here for 16 fiscal years, 2010 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Iovance Biotherapeutics, Inc. (IOVA) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/IOVA/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.